全文获取类型
收费全文 | 2840篇 |
免费 | 251篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 10篇 |
妇产科学 | 13篇 |
基础医学 | 339篇 |
口腔科学 | 18篇 |
临床医学 | 198篇 |
内科学 | 237篇 |
皮肤病学 | 14篇 |
神经病学 | 107篇 |
特种医学 | 66篇 |
外国民族医学 | 1篇 |
外科学 | 76篇 |
综合类 | 288篇 |
预防医学 | 35篇 |
眼科学 | 10篇 |
药学 | 1282篇 |
中国医学 | 127篇 |
肿瘤学 | 380篇 |
出版年
2024年 | 8篇 |
2023年 | 39篇 |
2022年 | 80篇 |
2021年 | 107篇 |
2020年 | 66篇 |
2019年 | 80篇 |
2018年 | 119篇 |
2017年 | 105篇 |
2016年 | 120篇 |
2015年 | 148篇 |
2014年 | 164篇 |
2013年 | 521篇 |
2012年 | 146篇 |
2011年 | 149篇 |
2010年 | 115篇 |
2009年 | 121篇 |
2008年 | 158篇 |
2007年 | 128篇 |
2006年 | 119篇 |
2005年 | 85篇 |
2004年 | 82篇 |
2003年 | 80篇 |
2002年 | 84篇 |
2001年 | 53篇 |
2000年 | 36篇 |
1999年 | 57篇 |
1998年 | 43篇 |
1997年 | 25篇 |
1996年 | 39篇 |
1995年 | 34篇 |
1994年 | 23篇 |
1993年 | 21篇 |
1992年 | 10篇 |
1991年 | 18篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 7篇 |
1985年 | 5篇 |
1984年 | 1篇 |
排序方式: 共有3211条查询结果,搜索用时 15 毫秒
1.
肺癌是目前全球发病率和死亡率均居前列的恶性肿瘤,其中肺鳞癌经手术、放化疗等综合治疗后,其疗效仍不满意。随着分子靶向治疗在肺腺癌中取得了令人瞩目的成果,而肺鳞癌患者中EGFR基因突变及ALK融合基因少见,急需探索新的靶点指导肺鳞癌患者的临床治疗。研究表明,FGFR家族(FGFR1-4)是肺鳞癌中突变频率较高的基因,FGFR基因的激活突变和扩增与肺鳞癌的发生和发展密切相关,同时许多小分子 FGFR 抑制剂在临床应用中已经取得较好的治疗效果。目前,许多FGFR抑制剂治疗肺鳞癌的临床试验也正在进行研究,针对FGFR靶点的基因治疗可为肺鳞癌的治疗提供一种新的策略。本文就FGFR在肺鳞癌的靶向治疗中的最新研究进展进行综述。 相似文献
2.
荧光分光光度法检测半乳糖化白蛋白磁性阿霉素纳米粒在大鼠体内分布的研究 总被引:1,自引:0,他引:1
目的观察由半乳糖化白蛋白磁性纳米粒运载的阿霉素经舌静脉给药后在大鼠体内的的分布状况.方法全部大鼠随机分为四组,经舌静脉,按分组分别注射相应药物,剂量均为阿霉素2.5 mg/kg体重.取全血、心、肺、肝、脾、肾.全血制成血浆,器官组织制成匀浆,盐酸乙醇法提取阿霉素,用荧光光度计测量.结果静脉注射同等剂量、不同剂型的阿霉素药物后,阿霉素在器官中的蓄积程度从高到低:肝:D靶肝>D非靶肝、C>B>A;心脏、肾、血浆:A>B>D、C;脾:B>A、C、D;肺:B>A>C、D.磁性阿霉素白蛋白纳米粒注入体内后,在心、肺、肝、脾、肾中的药物浓度在15~30min达峰值,而半乳糖化后,阿霉素的药物峰值提前到5 min或之前.外加磁场和未加磁场的半乳糖化白蛋白磁性阿霉素纳米粒组的药物靶向指数和药物选择指数是均高于磁性白蛋白纳米粒.结论磁性阿霉素白蛋白纳米粒经半乳糖化后,可显著增强阿霉素对肝脏的靶向性,并显著降低心、肺、脾、肾、血浆肝外器官的组织阿霉素浓度.利用外加磁场,可提高阿霉素在肝脏特定部位蓄积的能力.因此,静脉注射半乳糖化白蛋白磁性阿霉素纳米粒是可行的. 相似文献
3.
Venous and arterial thrombosis are closely related to many severe diseases, especially to cardiovascular and cerebrovasular disorders. Thrombolytic therapy has been proven to be an effective method to treat such disease, which decreased the mortality and morbidity greatly. 相似文献
4.
Purpose. To determine whether the non-toxic pentameric B subunit of Cholera toxin (CTB) binding to ganglioside GM1 on both the lipid vesicles and epithelial cells may provide a means to target lipid vesicles to mucosal cells expressing surface GM1.
Methods. Sonicated lipid vesicles containing ganglioside GM1 were prepared. Inter-vesicle cross-linking due to pentameric CTB binding to these GM1 vesicles was determined with a sub-micron particle analyzer. Association of CTB to GM1 vesicles was analyzed with continuous sucrose gradient centrifugation. CTB-mediated binding of GM1 vesicles to human mucosal epithelial cells (Caco-2 and HT-29), mucous membranes of mouse trachea, and nasal tissues were detected with fluorescent labeled vesicles.
Results. An increase in lipid particle size due to binding of CTB to lipid vesicles and inter-vesicles cross-linking was detected. At a 30-to-1 mole ratio of membrane-bound GMl-to-CTB, optimum increase in GM1 vesicle aggregation, was detected. Under such conditions, all the added CTB molecules were associated with GM1 vesicles. Time course analysis showed that inter-vesicles cross linking by CTB was detectable within 10 min. and reached a maximum value at 60 min. CTB associated GM1-vesicles bind to mucosal epithelial cells HT-29 and Caco-2 with similar affinity [Kd = 7.8 × 10–4 M lipid (Caco-2) and 7.6 × 10–4 M lipid (HT-29)]. GM1 mediated binding specificity was demonstrated by blocking with anti-GMl antibody and the insignificant degree of CTB-associated GM1 vesicle binding to GM1 deficient C6 cells.
Conclusions. The CTB-mediated GM1 binding to multiple membrane surfaces provides selective localization of GM1 vesicles to GM1 expressing mucosal cells and tissues. The strategy may be useful in localizing drugs and proteins to gut and respiratory tract mucosa. 相似文献
5.
6.
观察双特异性单克隆抗体介导的人单核-巨噬细胞在裸鼠体内对肝癌生长的抑制作用。用化学交联法制备双特异性单克隆抗体HAb18-MAb7及HAb18F(ab)2-MAb7F(ab'_2,并将其与单核-巨噬细胞-同注入荷人肝癌裸鼠体内,观察肿瘤体积的变化。 相似文献
7.
Data from a 1988 national drinking survey was cluster analysedto identify different types of male drinkers, to assist in thetargeting of health promotion strategies. Of the five segmentsgenerated by the clustering, one labelled Young Heavy DrinkingMales was identified as the most appropriate target segment,because although they were the segment reporting the highestlevel of alcohol-related problems they were also the segmentmost likely to feel they were drinking too much They were thereforethe segment most likely to be responsive to advertising thatsought to support people who wanted to change their drinkinghabits. They were also the most appropriate target for the longer-termgoal of changing the climate of opinion regarding the acceptabilityof more moderate drinking. Comparisons with two previous clusteranalyses showed a high degree of similarity, suggesting thatclustering is a reliable vehicle for identifying drinker types. 相似文献
8.
Takakura Yoshinobu Fujita Takuya Hashida Mitsuru Sezaki Hitoshi 《Pharmaceutical research》1990,7(4):339-346
As part of the strategy for the design of macromolecular carriers for drug targeting, the disposition characteristics of macromolecules were studied in mice bearing tumors that served as target tissues. Eight kinds of macromolecules including four polysaccharides and four proteins with different molecular weights and electric charges were used; tissue distribution and tumor localization after intravenous injection were studied. Pharmacokinetic analysis revealed that the tissue radioactivity uptake rate index calculated in terms of clearance was different among the tested compounds; especially, the urinary radioactivity excretion clearances and the total hepatic radioactivity uptake clearances varied widely. Compounds with low molecular weights (approximately 10 kD) or positive charges showed lower tumor radioactivity accumulation; radioactivity was rapidly eliminated from the plasma via rapid urinary excretion or extensive hepatic uptake, respectively. On the other hand, large and negatively charged compounds, carboxymethyl dextran, bovine serum albumin, and mouse immunoglobulin G, showed higher radioactivity accumulation in the tumor (calculated total amounts were 15.6, 10.8, and 20.8% of the dose, respectively) and prolonged retention in the circulation. These results demonstrated that the total systemic exposure rather than the uptake rate index was correlated with total tumor uptake. Molecular weight and electric charge of the macromolecules significantly affected their disposition characteristics and, consequently, determined radioactivity accumulation in the tumor. It was concluded that a drug–carrier complex designed for systemic tumor targeting should be polyanionic in nature and larger than 70,000 in molecular weight. 相似文献
9.
M. Eiro T. Katoh F. Ushikubi S. Narumiya T. Watanabe 《Clinical and experimental nephrology》2002,6(2):85-90
Background. Thromboxane (TX) A2 inhibition or prostaglardin (PGI2) infusion prevents ischemic acute renal failure (ARF) in animal models. However, the pathophysiological roles of the prostanoid
receptors in the development of ischemic ARF are not fully understood, partly because of the limited specificity of their
inhibitors or antagonists.
Methods. We investigated whether targeted disruption of the PGI2 receptor (IP) or TXA2 receptor (TP) genes conferred susceptibility to renal ischemic-reperfusion injury, using IP and TP knockout mice.
Results. Serum creatinine concentration in TP knockout mice was not significantly different from that in wild-type controls. There
were no significant histological differences between TP knockout and wild-type mice. Likewise, IP knockout mice showed no
significant differences from the wild-type controls in regard to creatinine concentration or histological damage.
Conclusions. Lack of TP or IP had no influence on postischemic ARF in mice, indicating that receptors for TXA2 or PGI2 may have minimal roles in the development of this mouse model of ischemic ARF.
Received: July 5, 2001 / Accepted: April 8, 2002 相似文献
10.
目的:构建串联的MYC反应元件修饰人端粒酶逆转录酶(hTERT)核心启动子引导酵母胞嘧啶脱氨酶基因Fcy1表达的复制缺陷型腺病毒载体。方法:将串联的MYC反应元件修饰的hTERT核心启动子及下游酵母胞嘧啶脱氨酶基因Fcy1克隆到穿梭质粒pDC316上,上辅助质粒pBHGlox(delta)E1,3Cre共转染HEK293细胞获得重组复制缺陷型腺病毒并在HEK293细胞中扩增重组病毒。PCR法及斑形成实验鉴定重组腺病毒和病毒滴度。结果:成功获得由6倍和18倍MYC反应元件修饰hTERT核心启动子引导Fcy1基因表达的复制缺陷型腺病毒载体。结论:MYC反应元件修饰hTERT核心启动子引导Fcy1基因表达的腺病毒载体为进一步研究骨肉瘤转录靶向基因治疗奠定了基础。 相似文献